Published in Semin Liver Dis on January 01, 1999
Enhancing Detection of Small Esophageal Varices by PillCam ESO | NCT00911131
Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization. Dig Dis Sci (2006) 1.50
Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol (2012) 1.47
Treatment of portal hypertension. World J Gastroenterol (2012) 1.39
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut (2015) 1.20
Successful treatment of protein-losing enteropathy induced by intestinal lymphangiectasia in a liver cirrhosis patient with octreotide: a case report. J Korean Med Sci (2004) 1.13
Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations. Hepatol Int (2011) 1.04
Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status. Dig Dis Sci (2006) 1.04
Multidisciplinary management of patients with cirrhosis: a need for care coordination. Clin Gastroenterol Hepatol (2012) 1.02
Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis. Therap Adv Gastroenterol (2014) 1.00
A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage. Hepatology (2008) 0.97
Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver. Hepatol Int (2008) 0.96
Cirrhosis and its complications: evidence based treatment. World J Gastroenterol (2014) 0.93
Variceal Hemorrhage. Curr Treat Options Gastroenterol (2002) 0.93
Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wien Klin Wochenschr (2013) 0.93
Clinical pharmacology of portal hypertension. Gastroenterol Clin North Am (2010) 0.92
Endoscopic management of esophagogastric varices in Japan. Ann Transl Med (2014) 0.91
Management of portal hypertension. Postgrad Med J (2004) 0.90
Beta-blockers in liver cirrhosis. Ann Gastroenterol (2014) 0.90
Platelet count to spleen diameter ratio for the diagnosis of esophageal varices: Is it feasible? Can J Gastroenterol (2008) 0.90
Influence of transforming growth factor-beta1 gene polymorphism at codon 10 on the development of cirrhosis in chronic hepatitis B virus carriers. J Korean Med Sci (2010) 0.88
Hepatic venous pressure gradient: clinical use in chronic liver disease. Clin Mol Hepatol (2014) 0.87
Pathophysiology of portal hypertension and esophageal varices. Int J Hepatol (2012) 0.87
Acute esophageal variceal bleeding: Current strategies and new perspectives. World J Hepatol (2010) 0.87
The management of patients awaiting liver transplantation. Nat Rev Gastroenterol Hepatol (2009) 0.86
Improving survival in decompensated cirrhosis. Int J Hepatol (2012) 0.86
Management of portal hypertension in children. World J Gastroenterol (2012) 0.85
Risk factors for mortality in severe upper gastrointestinal bleeding. Int J Colorectal Dis (2004) 0.84
Transjugular intrahepatic portosystemic shunt. Clin Liver Dis (2014) 0.84
Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research. J Pediatr Gastroenterol Nutr (2011) 0.84
Changes in the clinical outcomes of variceal bleeding in cirrhotic patients: a 10-year experience in gangwon province, South Korea. Gut Liver (2012) 0.83
Esophageal capsule endoscopy. World J Gastroenterol (2008) 0.83
Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: a meta-analysis. World J Gastroenterol (2010) 0.83
Use of portal pressure studies in the management of variceal haemorrhage. World J Gastrointest Endosc (2012) 0.83
Nonselective beta-blockers in cirrhotic patients with no or small varices: A meta-analysis. World J Gastroenterol (2015) 0.83
The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82
Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement. World J Hepatol (2015) 0.82
High-risk esophageal varices in patients treated with locoregional therapies for hepatocellular carcinoma: evaluation with regular follow-up liver CT. Dig Dis Sci (2008) 0.81
Endoscopic management of esophageal varices. World J Gastrointest Endosc (2012) 0.81
Defining the threshold: new data on the ability of capsule endoscopy to discriminate the size of esophageal varices. Dig Dis Sci (2010) 0.81
Improved survival with the patients with variceal bleed. Int J Hepatol (2011) 0.81
MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding. World J Gastroenterol (2011) 0.81
Comparison of modified percutaneous transhepatic variceal embolization and endoscopic cyanoacrylate injection for gastric variceal rebleeding. World J Gastroenterol (2013) 0.80
Gamna-Gandy bodies of the spleen detected with susceptibility weighted imaging: maybe a new potential non-invasive marker of esophageal varices. PLoS One (2013) 0.79
Knowledge about non-invasive diagnostic tests for varices in liver cirrhosis: A questionnaire survey to the Gastroenterology Branch of the Liaoning Medical Association, China. Gastroenterol Rep (Oxf) (2015) 0.79
Pathophysiology of portal hypertension and its clinical links. J Clin Exp Hepatol (2011) 0.79
Multidetector computed tomography versus platelet/spleen diameter ratio as methods for the detection of gastroesophageal varices. Ann Gastroenterol (2016) 0.78
Management of acute variceal bleeding. Clin Endosc (2014) 0.78
Esophageal Capsule Endoscopy for Screening Esophageal Varices among Japanese Patients with Liver Cirrhosis. Gastroenterol Res Pract (2011) 0.78
Practice patterns in screening for varices: an American survey. Dig Liver Dis (2009) 0.78
Factors impacting physicians' decisions to prevent variceal hemorrhage. BMC Gastroenterol (2015) 0.78
Prevention and management of variceal hemorrhage. Int J Hepatol (2013) 0.78
Primary prevention of variceal bleeding: pharmacological therapy versus endoscopic banding. N Am J Med Sci (2013) 0.78
Prevention and management of gastroesophageal varices in cirrhosis. Int J Hepatol (2012) 0.78
Quality improvement in gastroenterology clinical practice. Clin Gastroenterol Hepatol (2012) 0.77
An assessment of surgery for portal hypertensive patients performed at a single community hospital. Surg Today (2010) 0.77
Recent advances in the management of variceal bleeding. Gastroenterol Rep (Oxf) (2017) 0.76
Management by the intensivist of gastrointestinal bleeding in adults and children. Ann Intensive Care (2012) 0.76
High-risk esophageal varices in patients treated with locoregional therapy for hepatocellular carcinoma: assessment with liver computed tomography. World J Gastroenterol (2012) 0.76
Is it time to replace propranolol with carvedilol for portal hypertension? World J Gastrointest Endosc (2015) 0.76
Current Management of Esophageal Varices. Curr Treat Options Gastroenterol (2003) 0.76
Is transient Elastography a valid screening method for esophageal varices? Saudi J Gastroenterol (2016) 0.75
Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers. Am J Gastroenterol (2016) 0.75
Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices. World J Gastroenterol (2014) 0.75
Effects of phased joint intervention on Rho/ROCK expression levels in patients with portal hypertension. Exp Ther Med (2016) 0.75
A randomized controlled study of fuzheng huayu capsule for prevention of esophageal variceal bleeding in patients with liver cirrhosis. Evid Based Complement Alternat Med (2013) 0.75
Addition of Somatostatin After Successful Endoscopic Variceal Ligation Does not Prevent Early Rebleeding in Comparison to Placebo: A Double Blind Randomized Controlled Trial. J Clin Exp Hepatol (2015) 0.75
Is computerised tomography better than fibreoptic gastroscopy for early detection of gastric varices? Prz Gastroenterol (2016) 0.75
The safety and efficacy of gastric fundal variceal obliteration using N-butyl-2-cyanoacrylate; the experience of a single canadian tertiary care centre. Saudi J Gastroenterol (2013) 0.75
Gastrointestinal bleeding: Secondary prophylaxis for variceal bleeding. Nat Rev Gastroenterol Hepatol (2010) 0.75
Variceal bleeding in cirrhotic patients: risk factors, evolution, treatment. Clujul Med (2013) 0.75
Towards noninvasive detection of oesophageal varices. Int J Hepatol (2012) 0.75
Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension. ISRN Hepatol (2013) 0.75
Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function. BMJ Open Gastroenterol (2016) 0.75
Comparison of inpatient and outpatient upper gastrointestinal haemorrhage. Int J Colorectal Dis (2004) 0.75
Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis. Clin Mol Hepatol (2016) 0.75
Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active bleeding or stigmata increases the risk of rebleeding. Clin Mol Hepatol (2016) 0.75
Role of endoscopy in management of gastrointestinal complications of portal hypertension. World J Gastrointest Endosc (2015) 0.75
Circadian pattern of acute variceal bleeding among cirrhotic Egyptian patients. Indian J Hematol Blood Transfus (2009) 0.75
Feasibility of transnasal endoscopy in screening for esophageal and gastric varices in patients with chronic liver disease. Endosc Int Open (2017) 0.75
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet (2006) 15.32
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med (2001) 6.38
Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet (1995) 6.06
Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 5.09
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation (2001) 3.96
Health services: an Italian market. Lancet (1996) 3.43
Ramipril and the development of diabetes. JAMA (2001) 3.38
The treatment of portal hypertension: a meta-analytic review. Hepatology (1995) 3.11
Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology (1990) 2.99
Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology (1996) 2.96
Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol (2001) 2.93
Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA (2000) 2.76
Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology (2000) 2.57
Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation (2001) 2.30
Smoking habits and recurrence in Crohn's disease. Gastroenterology (1994) 2.30
Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci (1991) 2.12
Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology (1998) 2.10
Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci (1986) 2.07
Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology (1999) 2.02
Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis. Hepatology (1989) 1.97
Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J (2004) 1.90
Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet (1991) 1.88
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology (1998) 1.87
Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol (1997) 1.85
Gastric mucosal vascular ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I. Gastroenterology (1987) 1.77
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction. Hepatology (1988) 1.74
Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology (1983) 1.67
Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology (2000) 1.67
Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology (1993) 1.67
Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology (1999) 1.64
Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group. Gastroenterology (1996) 1.64
Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology (1991) 1.62
Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology (2001) 1.62
Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Hepatology (1999) 1.62
Chronic hepatitis C and interferon alpha: conventional and cumulative meta-analyses of randomized controlled trials. Am J Gastroenterol (1999) 1.60
Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin Gastroenterol (1997) 1.60
The lung in patients with cirrhosis. J Hepatol (1990) 1.59
Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology (1992) 1.57
Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J Hepatol (1998) 1.55
Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology (1988) 1.53
Hepatitis C virus replication in 'autoimmune' chronic hepatitis. J Hepatol (1991) 1.52
Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients. Hepatology (1983) 1.49
Testing non-linearity and directedness of interactions between neural groups in the macaque inferotemporal cortex. J Neurosci Methods (1999) 1.49
Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension. Gastroenterology (1998) 1.47
Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension. Gastroenterology (1992) 1.45
Limitations of laser-Doppler velocimetry and reflectance spectrophotometry in estimating gastric mucosal blood flow. Am J Physiol (1992) 1.43
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut (2008) 1.43
TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology (1999) 1.42
Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan. J Invasive Cardiol (2000) 1.41
Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci (1988) 1.40
Urate levels as a predictor of cardiac deaths: causal relation or mere association? Eur Heart J (2002) 1.40
Oral administration of clonidine in patients with alcoholic cirrhosis. Hemodynamic and liver function effects. Gastroenterology (1992) 1.40
Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials. J Hepatol (1991) 1.40
[Terlipressin in the treatment of portal hypertension]. Gastroenterol Hepatol (1998) 1.39
[Epidemiology of head traumas. "Barcelona" data base. Objectives, design and analysis of 584 cases]. Rev Esp Anestesiol Reanim (1992) 1.38
Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology (1984) 1.36
The molecular nature of the F-actin binding activity of aldolase revealed with site-directed mutants. J Biol Chem (1996) 1.32
In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis. J Antimicrob Chemother (1986) 1.32
Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology (2001) 1.29
Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology (2001) 1.28
Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse. Cancer Gene Ther (1999) 1.28
Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol (1992) 1.27
Antibiotic resistance of Streptococcus pneumoniae in childhood carriers. J Antimicrob Chemother (1987) 1.26
Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology (1981) 1.25
The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators. Can J Cardiol (1998) 1.22
Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. Clin Chem (1991) 1.20
Liver transplantation: the Italian experience. Dig Liver Dis (2002) 1.19
Hepatitis C virus and Sjögren's syndrome. Lancet (1992) 1.19
Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis (1987) 1.17
Bone remodelling in human immunodeficiency virus-1-infected patients. A histomorphometric study. Bone (1995) 1.17
Developing and establishing bee species as crop pollinators: the example of Osmia spp. (Hymenoptera: Megachilidae) and fruit trees. Bull Entomol Res (2002) 1.17
Mortality and causes of death in celiac disease in a Mediterranean area. Dig Dis Sci (1999) 1.16
Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis. Antimicrob Agents Chemother (1986) 1.16
Long-term course of interferon-treated chronic hepatitis C. J Hepatol (1998) 1.15
High survival rate of 43% in out-of-hospital cardiac arrest patients in an optimised chain of survival. Neth Heart J (2015) 1.15
Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study. Clin Nephrol (2005) 1.15
Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology (1980) 1.14
Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of 4 randomized clinical trials. J Hepatol (1992) 1.14
Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension. Hepatology (1998) 1.14
Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol (1992) 1.13
Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group. Hepatology (1991) 1.13
CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1. J Immunol (2001) 1.13
Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients. Cancer (1985) 1.12
Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology (1999) 1.12
Family functioning and psychosocial adjustment in overweight youngsters. Int J Eat Disord (2000) 1.12
Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial. Dig Dis Sci (1983) 1.12
Hemodynamic evaluation of the patient with portal hypertension. Semin Liver Dis (1986) 1.12
Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital. Gastroenterology (1990) 1.11
Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial. Diabetologia (2011) 1.10
Pseudocysts in acute nonalcoholic pancreatitis: incidence and natural history. Dig Dis Sci (1999) 1.10
Standardised pre-hospital care of acute myocardial infarction patients: MISSION! guidelines applied in practice. Neth Heart J (2010) 1.10
Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology (1985) 1.09